Medtronic (MDT) Gets FDA Approval For Epilepsy Treatment
By Daniel James Hayden IV
March 12, 2010 6:45 PM
March 12, 2010 6:45 PM
Symbols: MDT
The Associated Press reported on Friday that a panel at the Food and Drug Administration approved a brain stimulator made by Medtronic Inc. (NYSE: MDT) for the treatment of epilepsy.
The panel voted 7 to 5 in favor of the approval and said that Medtronic must conduct follow-up studies of the brain stimulator to determine whether or not the device is a safe way to treat epilepsy.
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
We're Loving
